Dermatologic Manifestations Among Transplant Recipients

Organ transplantation constitutes a life-saving intervention for persons with end-stage organ disease. Long-term immunosuppressant therapy is essential for graft survival but results in reduced immunosurveillance, which leads to an increased risk of complications. A variety of dermatologic manifestations including a large increase in nonmelanoma skin cancers have been reported in this population. The purpose of this chapter is to describe the clinical spectrum of cutaneous manifestations in solid transplant recipients regarding epidemiology, etiopathogenesis, clinical presentation, and therapeutic approach.